Number of patients per cohort and sample size considerations using dose escalation with overdose control

DOI10.1155/2012/692725zbMath1282.62236OpenAlexW1974454023WikidataQ58910979 ScholiaQ58910979MaRDI QIDQ1929695

André Rogatko, Mourad Tighiouart

Publication date: 9 January 2013

Published in: Journal of Probability and Statistics (Search for Journal in Brave)

Full work available at URL: https://doi.org/10.1155/2012/692725

Mathematics Subject Classification ID

Applications of statistics to biology and medical sciences; meta analysis (62P10)

Related Items (2)

Number of patients per cohort and sample size considerations using dose escalation with overdose control ⋮ Adaptive clinical trial designs for phase I cancer studies

Uses Software

• EWOC

Cites Work

• Continual Reassessment Method: A Practical Design for Phase 1 Clinical Trials in Cancer
• Dose finding with escalation with overdose control (EWOC) in cancer clinical trials
• Optimal Bayesian-feasible dose escalation for cancer phase I trials
• Number of patients per cohort and sample size considerations using dose escalation with overdose control
• Dose finding in drug development.
• Statistical properties of the traditional algorithm-based designs for phase I cancer clinical trials

This page was built for publication: Number of patients per cohort and sample size considerations using dose escalation with overdose control